Oxycodone Actavis 5 mg Norwegia - Norwegia - Statens legemiddelverk

oxycodone actavis 5 mg

actavis group ptc ehf - oksykodonhydroklorid - kapsel, hard - 5 mg

Oxycodone Actavis 10 mg Norwegia - Norwegia - Statens legemiddelverk

oxycodone actavis 10 mg

actavis group ptc ehf - oksykodonhydroklorid - kapsel, hard - 10 mg

Oxycodone Vitabalans 5 mg Norwegia - Norwegia - Statens legemiddelverk

oxycodone vitabalans 5 mg

vitabalans oy - oksykodonhydroklorid - tablett, filmdrasjert - 5 mg

Oxycodone Vitabalans 10 mg Norwegia - Norwegia - Statens legemiddelverk

oxycodone vitabalans 10 mg

vitabalans oy - oksykodonhydroklorid - tablett, filmdrasjert - 10 mg

Phenoleptil 50 mg Norwegia - Norwegia - Statens legemiddelverk

phenoleptil 50 mg

le vet b.v. - fenobarbital - tablett - 50 mg

Phenoleptil 12.5 mg Norwegia - Norwegia - Statens legemiddelverk

phenoleptil 12.5 mg

le vet b.v. - fenobarbital - tablett - 12.5 mg

Lacosamide Accord Uni Eropa - Norwegia - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Stesolid 5 mg/ ml Norwegia - Norwegia - Statens legemiddelverk

stesolid 5 mg/ ml

actavis group ptc ehf (1) - diazepam - injeksjonsvæske, emulsjon - 5 mg/ ml

Lacosamide UCB Uni Eropa - Norwegia - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptics, - lacosamide ucb er indisert som monoterapi og tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.

Berinert 3000 IU Norwegia - Norwegia - Statens legemiddelverk

berinert 3000 iu

csl behring gmbh (2) - c1-esteraseinhibitor, human - pulver og væske til injeksjonsvæske, oppløsning - 3000 iu